Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8347769rdf:typepubmed:Citationlld:pubmed
pubmed-article:8347769lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:8347769lifeskim:mentionsumls-concept:C0024141lld:lifeskim
pubmed-article:8347769lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:8347769lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:8347769lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:8347769lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:8347769lifeskim:mentionsumls-concept:C1515021lld:lifeskim
pubmed-article:8347769lifeskim:mentionsumls-concept:C0076533lld:lifeskim
pubmed-article:8347769pubmed:issue4lld:pubmed
pubmed-article:8347769pubmed:dateCreated1993-9-16lld:pubmed
pubmed-article:8347769pubmed:abstractTextRelative reactivity of anti-lymphocyte autoantibodies (ALA) from patients with systemic lupus erythematosus (SLE) against CD4+ and CD8+ T cells was studied using C-dependent microcytotoxicity assay. Of 46 SLE sera screened for anti-T cell autoantibodies, 27 sera (59%) showed significant cytotoxic reactivity. Of these, positive correlation between the titer of anti-T cell antibody and CD4/CD8 killing ratio (p < 0.01) was demonstrated. In time course study of individual patients, the CD4/CD8 killing ratio increased and decreased as the disease flared and subsided and was accompanied by parallel changes in the titer of anti-T cell antibody titer. Moreover, as sera were serially diluted, the CD4/CD8 killing ratio decreased in 5 out of 10 sera. These results suggest that discrepancy among reports concerning the subset specificity of anti-T cell antibodies may be due, in part, to differences in the titer of ALA in the sera studied and to the dilution of serum used.lld:pubmed
pubmed-article:8347769pubmed:languageenglld:pubmed
pubmed-article:8347769pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8347769pubmed:citationSubsetIMlld:pubmed
pubmed-article:8347769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8347769pubmed:statusMEDLINElld:pubmed
pubmed-article:8347769pubmed:issn0891-6934lld:pubmed
pubmed-article:8347769pubmed:authorpubmed-author:YamadaAAlld:pubmed
pubmed-article:8347769pubmed:authorpubmed-author:YazakiYYlld:pubmed
pubmed-article:8347769pubmed:authorpubmed-author:NojimaYYlld:pubmed
pubmed-article:8347769pubmed:authorpubmed-author:MinotaSSlld:pubmed
pubmed-article:8347769pubmed:issnTypePrintlld:pubmed
pubmed-article:8347769pubmed:volume14lld:pubmed
pubmed-article:8347769pubmed:ownerNLMlld:pubmed
pubmed-article:8347769pubmed:authorsCompleteYlld:pubmed
pubmed-article:8347769pubmed:pagination269-73lld:pubmed
pubmed-article:8347769pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8347769pubmed:meshHeadingpubmed-meshheading:8347769-...lld:pubmed
pubmed-article:8347769pubmed:meshHeadingpubmed-meshheading:8347769-...lld:pubmed
pubmed-article:8347769pubmed:meshHeadingpubmed-meshheading:8347769-...lld:pubmed
pubmed-article:8347769pubmed:meshHeadingpubmed-meshheading:8347769-...lld:pubmed
pubmed-article:8347769pubmed:meshHeadingpubmed-meshheading:8347769-...lld:pubmed
pubmed-article:8347769pubmed:meshHeadingpubmed-meshheading:8347769-...lld:pubmed
pubmed-article:8347769pubmed:meshHeadingpubmed-meshheading:8347769-...lld:pubmed
pubmed-article:8347769pubmed:meshHeadingpubmed-meshheading:8347769-...lld:pubmed
pubmed-article:8347769pubmed:meshHeadingpubmed-meshheading:8347769-...lld:pubmed
pubmed-article:8347769pubmed:year1993lld:pubmed
pubmed-article:8347769pubmed:articleTitleChanges in subset specificity of anti-T cell autoantibodies in systemic lupus erythematosus.lld:pubmed
pubmed-article:8347769pubmed:affiliationThird Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.lld:pubmed
pubmed-article:8347769pubmed:publicationTypeJournal Articlelld:pubmed